Cosmo Bio Co (TSE:3386) Marketable Securities: 円199 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:3386 Cosmo Bio Co Ltd TSE:3386
73 GF Score
Price 円1,266.00
GF Value 円1,251.05
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Cosmo Bio Co Marketable Securities?

Cosmo Bio Co TSE:3386 +1.12% 73 Marketable Securities is 円199 Mil as of Dec. 2025. GuruFocus rates TSE:3386 with a GF Score™ of 73/100 and a GF Value™ of 円1,251.05 (Fairly Valued). The stock has 4 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Cosmo Bio Co's Marketable Securities for the quarter that ended in Dec. 2025 was 円199 Mil.

Cosmo Bio Co's annual Marketable Securities increased from Dec. 2023 (円199 Mil) to Dec. 2024 (円300 Mil) but then declined from Dec. 2024 (円300 Mil) to Dec. 2025 (円199 Mil).

Cosmo Bio Co  (TSE:3386) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Cosmo Bio Co Marketable Securities Related Terms

Cosmo Bio Co Marketable Securities Historical Data

* Premium members only.

The historical data trend for Cosmo Bio Co's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cosmo Bio Co Marketable Securities Chart

Cosmo Bio Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 300.00 0.00 199.00 300.00 199.00

Cosmo Bio Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 199.00 199.00 300.00 299.00 199.00
TSE:3386
73GF Score
Cosmo Bio Co Ltd TSE:3386
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cosmo Bio Co Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of 円199 Mil mean?
Cosmo Bio Co (TSE:3386) has a Marketable Securities of 円199 Mil as of Dec. 2025. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Cosmo Bio Co and its competitors.
Is Cosmo Bio Co's Marketable Securities too high?
Cosmo Bio Co's current Marketable Securities is 円199 Mil. Overall, Cosmo Bio Co has a GF Score™ of 73/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Cosmo Bio Co's Marketable Securities compare to TMO and DHR?
Cosmo Bio Co's Marketable Securities of 円199 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Diagnostics & Research company?
A good Marketable Securities depends on the Medical Diagnostics & Research industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Cosmo Bio Co and its competitors. Cosmo Bio Co's current Marketable Securities is 円199 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cosmo Bio Co stock overvalued right now?
Based on GuruFocus' analysis, Cosmo Bio Co (TSE:3386) is currently considered Fairly Valued. The stock's GF Value™ is 円1,251.05, compared to a current price of 円1,266.00 — trading 1.2% above its estimated fair value. The current Marketable Securities is 円199 Mil. Cosmo Bio Co's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Cosmo Bio Co (TSE:3386), the current Marketable Securities is 円199 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cosmo Bio Co (TSE:3386) Overvalued in 2026?

Based on GuruFocus' analysis, Cosmo Bio Co stock appears to be overvalued. The current stock price of 円1,266.00 is trading 1.2% above its estimated GF Value™ of 円1,251.05. GuruFocus considers Cosmo Bio Co to be Fairly Valued.

Key valuation signals for TSE:3386:

  • Marketable Securities: 円199 Mil
  • GF Value™: 円1,251.05 vs. price of 円1,266.00 (1.2% above fair value)
  • GF Score™: 73/100 with 4 warning signs

No single metric tells the full story. See the TSE:3386 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cosmo Bio Co Business Description

Address 2-20, Toyo-Ekimae Building, Toyo 2-Chome, Koto-ku, Tokyo, JPN, 135-0016
Cosmo Bio Co Ltd is a diagnostic and research company based in Japan. The business of the company includes the purchase of reagents, instruments, and clinical test drugs for research in life science and domestic sales.
73GF Score

Get the complete analysis for TSE:3386

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円1,266.00
Price
円1,251.05
GF Value